Gossamer Bio, Inc. Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue17.0M13.8M13.3M11.5M9.9M9.4M9.5M95.8M
Cost of Goods Sold232K0000000
Gross Profit16.7M13.8M13.3M11.5M9.9M9.4M9.5M95.8M
R&D Expenses43.1M48.9M53.0M41.6M38.0M36.1M34.9M35.1M
Operating Expenses61.6M59.8M62.4M50.3M46.7M45.5M43.4M43.8M
Operating Income-44.9M-46.0M-49.1M-38.8M-36.8M-36.1M-33.9M52.1M
Other Income / Gains-1.8M-1.3M893K492K172K689K2.0M1.6M
Net Income-46.7M-47.2M-48.2M-38.3M-36.6M-33.0M-30.8M49.2M
EPS (Diluted)-0.20-0.21-0.21-0.17-0.16-0.15-0.140.22
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.9861.001.001.001.001.001.001.00
General And Administrative Expenses18.7M10.9M9.4M8.7M8.7M9.4M8.5M8.7M
Selling And Marketing Expenses00000000
Selling General And Administrative Expenses18.7M10.9M9.4M8.7M8.7M9.4M8.5M8.7M
Other Expenses-227K0000000
Cost And Expenses61.8M59.8M62.4M50.3M46.7M45.5M43.4M43.8M
Interest Income354K447K687K542K294K-744K430K1.7M
Interest Expense2.8M2.8M2.7M2.7M2.7M2.7M2.7M2.9M
Depreciation And Amortization232K227K6K213K342K1.1M1.1M992K
Ebitda-43.7M-44.3M-45.5M-35.3M-33.5M-31.6M-28.1M57.6M
Ebitdaratio-2.576-3.214-3.42-3.074-3.393-3.372-2.9640.601
Operating Income Ratio-2.646-3.336-3.694-3.374-3.722-3.852-3.5780.543
Income Before Tax-46.7M-47.3M-48.2M-38.3M-36.6M-35.4M-31.9M53.7M
Income Before Tax Ratio-2.752-3.43-3.627-3.331-3.705-3.779-3.3690.56
Income Tax Expense0-88K000-2.4M-1.1M4.4M
Net Income Ratio-2.752-3.423-3.627-3.331-3.705-3.522-3.2490.514
Epsdiluted-0.20-0.21-0.21-0.17-0.16-0.15-0.140.21
Weighted Average Shs Out234.1M226.6M228.0M227.3M226.8M226.6M226.3M226.2M
Weighted Average Shs Out Dil234.1M226.6M228.0M227.3M226.8M226.6M226.3M238.5M